NeoPhotonics Reports Second Quarter 2022 Financial Results

Rhea-AI Summary

NeoPhotonics reported $95 million in revenue for Q2 2022, achieving a 46% year-over-year growth, despite supply chain issues impacting revenue by approximately $10 million. The company noted that products for 400G and above applications comprised 64% of revenue, reflecting a 105% increase year-over-year. GAAP operating profit improved to $6.4 million, up from a loss of $16.3 million in Q2 2021. Adjusted EBITDA was $13.2 million, emphasizing a notable recovery in performance. The company anticipates continued growth despite ongoing supply challenges.

Positive

• Revenue of $95 million reflects a 46% year-over-year growth.
• 400G and above products contributed 64% of revenue, growing 105% year-over-year.
• GAAP operating profit of $6.4 million, a significant turnaround from a loss of $16.3 million last year.
• Adjusted EBITDA increased to $13.2 million from $7.8 million in the prior quarter.

Negative

• Supply chain issues negatively impacted revenue by approximately $10 million.
• Demand remains strong, but chip supply shortages continue to constrain revenue.
• Net cash decreased by approximately $2 million from Q1 2022.

• Revenue of $95.0 million represents 46% year-over-year growth over same quarter last year
• Second sequential quarter with 45+% year-over-year growth; first half revenue of $184 million up 46% from same period last year
• $61 million of revenue from products for 400G and above applications, contributing 64% of revenue and representing approximately 105% year-over-year growth
• GAAP Operating Profit of $6.4 million, up from a loss of $16.3 million in the same period last year on the strength of the 400G product ramp

SAN JOSE, Calif.--(BUSINESS WIRE)-- NeoPhotonics Corporation (NYSE: NPTN), a leading developer of silicon photonics and advanced hybrid photonic integrated circuit-based lasers, modules and subsystems for bandwidth-intensive, high-speed communications networks, today announced financial results for its second quarter of 2022.

“Our business remains on a strong growth path with revenue of $95 million, 46% above the same quarter last year and also up 46% year-to-date. This was despite ongoing supply chain limitations which had an adverse impact on revenue of approximately $10 million. Our 400G and above products grew approximately 105% year-over-year, and now comprise 64% of total revenue. Our revenue from 400ZR coherent DCO module products to datacenter customers is now in low millions per quarter,” said Tim Jenks, Chairman and CEO of NeoPhotonics. “In addition to 400ZR, we are ramping our 96 Gbaud components and sampling 130 Gbaud for even higher data rate applications. These new component products, together with our ramping 400ZR and CFP2 400G module products, give us confidence in continued growth for the quarters ahead, despite the expected challenges with IC chip supply shortages.”

Mr. Jenks continued, “I would like to thank NeoPhotonics employees for their continued commitment, which has built the Company’s strong technology leadership for high speed over distance applications and has resulted in the Company’s strong performance in the second quarter of 2022.”

Mr. Jenks concluded, “The Lumentum transaction, announced last November, remains on track having been approved by our shareholders and received antitrust clearance from US regulators. We look forward to securing regulatory approval in China and closing the transaction. Our strong quarter with more than 46% year over year revenue growth, GAAP operating profit and significant growth from western customers, reflects our success in pivoting our business following the loss of revenue in 2020 due to Department of Commerce restrictions on certain Chinese customers.”

Second Quarter 2022 Summary

• Revenue of $95.0 million was up 46% year-over-year on growth in 400G and above capable products and up 6% quarter-over-quarter. Supply chain shortages negatively impacted revenue by approximately $10 million in the second quarter. Demand remains strong and chip supply continues to constrain revenue.
• Three customers were greater than 10% of our revenue for the three months ended June 30, 2022 and our top five customers accounted for 83% of our revenue in the quarter versus 77% in the same quarter last year.
• Gross margin was 34.8%, up nearly 20 percentage points year-over-year on improved factory utilization and up 4.2 percentage points from the prior quarter on meaningful yield improvements.
• Non-GAAP gross margin was 35.2% up from 21.7% in the same quarter last year and 31.2% in the prior quarter.
• Operating expense was $26.7 million, down $3.4 million from Q1’22 on a gain on the sale of our Fremont wafer fab and lower costs related to the sale.
• Non-GAAP operating expense of $24.1 million, down $0.9 million from Q1’22 on lower R&D materials & operating costs of the Fremont site.
• Operating income was $6.4 million, compared to a loss of $2.8 million in Q1’22 and a loss of $16.3 million in Q2’21, driven by the significant improvement in revenue and gross margin.
• Non-GAAP operating income was $9.4 million, compared to a loss of $10.3 million in Q2’21 and a profit of $2.8 million in the prior quarter, a notable turnaround in results.
• Foreign Exchange was a gain of $6.0 million on the appreciation of the U.S. dollar. As a reminder, the foreign exchange impact is largely related to the revaluation of U.S. dollar assets on our overseas books which are stated in their local currency. Beginning this quarter, we will exclude unrealized foreign exchange from our Non-GAAP results, to better focus on our operational results.
• Net earnings per share was $0.17, compared to net loss of $0.34 a year ago and a loss of $0.06 per share in the prior quarter.
• Non-GAAP net income per share was $0.15, compared to a Non-GAAP loss per share of $0.22 a year ago and a Non-GAAP earnings per share of $0.04 in the prior quarter. Excluding the impact of unrealized foreign exchange in the prior quarters, earnings per share was a loss of $0.22 in Q2’21 and an income of $0.05 in Q1’22.
• Adjusted EBITDA was $13.2 million, up from $7.8 million in the prior quarter excluding the impact of unrealized foreign exchange.
• Net Inventory grew $5.8 million from Q1’22, to $66 million, as we increased 400ZR inventories to a total of $20 million to ensure ongoing module supply.
• As of June 30, 2022, cash and cash equivalents, short-term investments and restricted cash totaled $105 million, down approximately $2.0 million from Q1’22. Capital Expenditure was $3 million.

Non-GAAP results in the second quarter of 2022 exclude gains of $5.4 million for unrealized foreign exchange, $1.9 million on the sale of assets, expenses of $2.6 million for stock-based compensation, $2.0 million of merger retention and other acquisition related charges, income tax effect of $1.4 million for Non-GAAP items and $0.2 million of other charges. A reconciliation of the non-GAAP and Adjusted EBITDA financial measures to the most directly comparable GAAP financial measures is provided in the financial schedules portion at the end of this press release.

NeoPhotonics Product Milestone Achievements

• Products capable of use for 400G and above applications were 64% of revenue in Q2 2022.
• Continued to ramp production of our 400ZR small form factor coherent transceiver modules, reaching low single digit millions in revenue.
• Shipped first samples of 130 Gbaud Coherent Receivers and Modulators for next generation 800G and 1.6T links.
• Conducted webinar outlining the application of NeoPhotonics coherent products and technology to Lidar for Autonomous Vehicles and other remote sensing applications.

Supply Chain Impacts

Second quarter revenue was approximately $10 million lower than we project it would have been without supply chain constraints. Supply chain impacts in the quarter were primarily shortages of analog and power semiconductors. The Company expects such impacts to continue through 2022.

Non-GAAP and Adjusted EBITDA Measures vs. GAAP Financial Measures

The Company’s non-GAAP and Adjusted EBITDA measures exclude certain GAAP financial measures. A reconciliation of the non-GAAP and Adjusted EBITDA financial measures to the most directly comparable GAAP financial measures is provided in the financial schedules portion at the end of this press release. These non-GAAP financial measures differ from GAAP measures with the same captions and may differ from non-GAAP financial measures with the same or similar captions that are used by other companies. As such, these non-GAAP measures should be considered as a supplement to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP.

The Company uses these non-GAAP financial measures to analyze its operating performance and future prospects, develop internal budgets and financial goals, and to facilitate period-to-period comparisons. NeoPhotonics believes that these non-GAAP financial measures reflect an additional way of viewing aspects of its operations that, when viewed with its GAAP results, provide a more complete understanding of factors and trends affecting its business.

Conference Call

The Company will not host a conference call regarding the Q2 2022 results.

About NeoPhotonics

NeoPhotonics is a leading developer and manufacturer of lasers and optoelectronic solutions that transmit, receive and switch high-speed digital optical signals for Cloud and hyper-scale data center internet content provider and telecom networks. The Company’s products enable cost-effective, high-speed over distance data transmission and efficient allocation of bandwidth in optical networks. NeoPhotonics maintains headquarters in San Jose, California and ISO 9001:2015 certified engineering and manufacturing facilities in Silicon Valley (USA), Japan and China. For additional information visit www.neophotonics.com.

Notice Regarding Forward-Looking Statements

This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events, including the timing of the proposed transaction, information related to the proposed transaction, and supply chain constraints. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these words or other similar terms or expressions that concern the proposed transaction and our expectations, strategy, plans or intentions regarding it. Forward-looking statements in this communication include, but are not limited to, (i) expectations regarding the timing, completion and expected benefits of the proposed transaction, (ii) expected continued supply chain impacts, plans, objectives and intentions with respect to future operations, customers and the market, and (iii) future growth and profitability. Expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These risks include the risk that the transaction may not be completed in a timely manner or at all; the ability to secure additional regulatory approvals on the terms expected in a timely manner or at all; the effect of the announcement or pendency of the transaction on our business relationships, results of operations and business generally; ability to win customer awards; risks that the proposed transaction disrupts current plans and operations; the risk of litigation and/or regulatory actions related to the proposed transaction; disruptions and shortages in supply chains; impact of inflation on our business; potential impacts of the Covid-19 pandemic; changing supply and demand conditions in the industry; and general market, political, economic, and business conditions. The forward-looking statements contained in this communication are also subject to other risks and uncertainties, including those more fully described in filings with the Securities and Exchange Commission ("SEC"), including reports filed on Form 10-K, 10-Q and 8-K and in other filings made by NeoPhotonics with the SEC from time to time and available at www.sec.gov. These forward-looking statements are based on current expectations, and are based on NeoPhotonics’ current expectations which is subject to change.

The parties undertake no obligation to update the information contained in this communication or any other forward-looking statement.

^©2022 NeoPhotonics Corporation. All rights reserved. NeoPhotonics and the red dot logo are trademarks of NeoPhotonics Corporation. All other marks are the property of their respective owners.

NeoPhotonics Corporation
Condensed Consolidated Balance Sheets (Unaudited)
(In thousands)
		As of
		Jun. 30, 2022				Dec. 31, 2021
ASSETS
Current assets:
Cash and cash equivalents		$	77,079			$	77,833
Short-term investments			27,720				27,675
Restricted cash			38				87
Accounts receivable, net			68,460				55,324
Inventories			65,510				52,896
Prepaid expenses and other current assets			18,927				16,246
Total current assets			257,734				230,061
Property, plant and equipment, net			49,191				54,190
Operating lease right-of-use assets			12,091				13,201
Purchased intangible assets, net			787				844
Goodwill			1,115				1,115
Other long-term assets			5,636				6,156
Total assets		$	326,554			$	305,567
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable		$	69,685			$	58,125
Short-term borrowing, net			—				14,914
Current portion of long-term debt			2,449				2,928
Accrued and other current liabilities			29,327				30,008
Total current liabilities			101,461				105,975
Long-term debt, net of current portion			23,945				25,753
Related party long-term debt			29,954				—
Operating lease liabilities, noncurrent			12,107				13,441
Other noncurrent liabilities			6,813				7,437
Total liabilities			174,280				152,606
Stockholders’ equity:
Common stock			134				133
Additional paid-in capital			614,553				610,085
Accumulated other comprehensive income (loss)			(8,782	)			2,376
Accumulated deficit			(453,631	)			(459,633	)
Total stockholders’ equity			152,274				152,961
Total liabilities and stockholders’ equity		$	326,554			$	305,567

NeoPhotonics Corporation
Condensed Consolidated Statements of Operations (Unaudited)
(In thousands, except percentages and per share data)
		Three Months Ended												Six Months Ended
		Jun. 30, 2022				Mar. 31, 2022				Jun. 30, 2021				Jun. 30, 2022				Jun. 30, 2021
Revenue		$	95,006			$	89,268			$	65,010			$	184,274			$	125,935
Cost of goods sold (1)			61,935				61,979				55,135				123,914				102,721
Gross profit			33,071				27,289				9,875				60,360				23,214
Gross margin			34.8	%			30.6	%			15.2	%			32.8	%			18.4	%
Operating expenses:
Research and development (1)			14,736				15,098				15,410				29,834				28,508
Sales and marketing (1)			3,742				3,686				3,362				7,428				7,227
General and administrative (1) (2)			9,228				9,794				7,398				19,022				14,692
Acquisition and asset sale related costs (recoveries)			638				905				(36	)			1,543				127
Restructuring charges			—				—				22				—				22
Asset impairment charges			30				413				—				443				—
Facility shutdown related costs			209				300				—				509				—
Litigation Settlement			(12	)			49				—				37				—
Gain on asset sale			(1,866	)			(114	)			—				(1,980	)			—
Total operating expenses			26,705				30,131				26,156				56,836				50,576
Income (loss) from operations			6,366				(2,842	)			(16,281	)			3,524				(27,362	)
Interest income			147				71				140				218				245
Interest expense			(510	)			(355	)			(220	)			(865	)			(447	)
Other income (expense), net			5,823				395				(880	)			6,218				263
Total interest and other income (expense), net			5,460				111				(960	)			5,571				61
Income (loss) before income taxes			11,826				(2,731	)			(17,241	)			9,095				(27,301	)
Income tax provision			(2,521	)			(572	)			(191	)			(3,093	)			(823	)
Net income (loss)		$	9,305			$	(3,303	)		$	(17,432	)		$	6,002			$	(28,124	)
Basic net income (loss) per share		$	0.17			$	(0.06	)		$	(0.34	)		$	0.11			$	(0.55	)
Diluted net income (loss) per share		$	0.17			$	(0.06	)		$	(0.34	)		$	0.11			$	(0.55	)
Weighted average shares used to compute basic net income (loss) per share			53,488				53,146				51,634				53,318				51,178
Weighted average shares used to compute diluted net income (loss) per share			56,095				53,146				51,634				55,999				51,178
(1) Includes stock-based compensation expense as follows for the periods presented:
Cost of goods sold		$	404			$	525			$	572			$	929			$	1,120
Research and development			794				774				744				1,568				1,606
Sales and marketing			400				385				261				785				815
General and administrative			1,011				931				763				1,942				2,076
Total stock-based compensation expense		$	2,609			$	2,615			$	2,340			$	5,224			$	5,617
(2) Includes $1,359 and $2,810 of retention costs related to the acquisition for the three and six months ended June 30, 2022, respectively.

NeoPhotonics Corporation
Reconciliation of Condensed Consolidated GAAP Financial Measures to Non-GAAP Financial Measures (Unaudited)
(In thousands, except percentages and per share data)
		Three Months Ended												Six Months Ended
		Jun. 30, 2022				Mar. 31, 2022				Jun. 30, 2021				Jun. 30, 2022				Jun. 30, 2021
NON-GAAP GROSS PROFIT:
GAAP gross profit		$	33,071			$	27,289			$	9,875			$	60,360			$	23,214
Stock-based compensation expense			404				525				572				929				1,120
Amortization of purchased intangible assets			7				8				153				15				338
Depreciation of acquisition-related fixed asset step-up			3				3				3				6				(3	)
End-of-life related inventory write-down			—				—				3,257				—				2,680
Accelerated depreciation			—				—				157				—				331
Restructuring charges (recoveries)			—				(18	)			113				(18	)			113
Non-GAAP gross profit		$	33,485			$	27,807			$	14,130			$	61,292			$	27,793
Non-GAAP gross margin as a % of revenue			35.2	%			31.2	%			21.7	%			33.3	%			22.1	%
NON-GAAP TOTAL OPERATING EXPENSES:
GAAP total operating expenses		$	26,705			$	30,131			$	26,156			$	56,836			$	50,576
Stock-based compensation expense			(2,205	)			(2,090	)			(1,768	)			(4,295	)			(4,497	)
Depreciation of acquisition-related fixed asset step-up			(12	)			(14	)			(21	)			(26	)			(46	)
Acquisition and asset sale related costs			(638	)			(905	)			36				(1,543	)			(127	)
Retention costs related to acquisition			(1,359	)			(1,451	)			—				(2,810	)			—
Restructuring charges			—				—				(22	)			—				(22	)
Asset impairment charges			(30	)			(413	)			—				(443	)			—
Facility shutdown related costs			(209	)			(300	)			—				(509	)			—
Litigation settlement			12				(49	)			—				(37	)			—
Gain on asset sale			1,866				114				—				1,980				—
Non-GAAP total operating expenses		$	24,130			$	25,023			$	24,381			$	49,153			$	45,884
Non-GAAP total operating expenses as a % of revenue			25.4	%			28.0	%			37.5	%			26.7	%			36.4	%
NON-GAAP OPERATING INCOME (LOSS):
GAAP income (loss) from operations		$	6,366			$	(2,842	)		$	(16,281	)		$	3,524			$	(27,362	)
Stock-based compensation expense			2,609				2,615				2,340				5,224				5,617
Amortization of purchased intangible assets			7				8				153				15				338
Depreciation of acquisition-related fixed asset step-up			15				17				24				32				43
Acquisition and asset sale related costs (recoveries)			638				905				(36	)			1,543				127
Retention costs related to acquisition			1,359				1,451				—				2,810				—
End-of-life related inventory write-down			—				—				3,257				—				2,680
Accelerated depreciation			—				—				157				—				331
Restructuring charges (recoveries)			—				(18	)			135				(18	)			135
Asset impairment charges			30				413				—				443				—
Facility shutdown related costs			209				300				—				509				—
Litigation settlement			(12	)			49				—				37				—
Gain on asset sale			(1,866	)			(114	)			—				(1,980	)			—
Non-GAAP income (loss) from operations		$	9,355			$	2,784			$	(10,251	)		$	12,139			$	(18,091	)
Non-GAAP operating margin as a % of revenue			9.8	%			3.1	%			(15.8	)%			6.6	%			(14.4	)%

NeoPhotonics Corporation
Reconciliation of Condensed Consolidated GAAP Financial Measures to Non-GAAP Financial Measures (Unaudited) (Continued)
(In thousands, except percentages and per share data)
		Three Months Ended												Six Months Ended
		Jun. 30, 2022				Mar. 31, 2022				Jun. 30, 2021				Jun. 30, 2022				Jun. 30, 2021
NON-GAAP NET INCOME (LOSS):
GAAP net income (loss)		$	9,305			$	(3,303	)		$	(17,433	)		$	6,002			$	(28,124	)
Stock-based compensation expense			2,609				2,615				2,340				5,224				5,617
Amortization of purchased intangible assets			7				8				153				15				338
Depreciation of acquisition-related fixed asset step-up			15				17				24				32				43
Acquisition and asset sale related costs (recoveries)			638				905				(36	)			1,543				127
Retention costs related to acquisition			1,359				1,451				—				2,810				—
End-of-life related inventory write-down			—				—				3,257				—				2,680
Accelerated depreciation			—				—				157				—				331
Restructuring charges (recoveries)			—				(18	)			135				(18	)			135
Asset impairment charges			30				413				—				443				—
Facility shutdown related costs			209				300				—				509				—
Litigation settlement			(12	)			49				—				37				—
Gain on asset sale			(1,866	)			(114	)			—				(1,980	)			—
Unrealized foreign exchange (gain) loss, net (3)			(5,386	)			555				(153	)			(4,831	)			(3,672	)
Income tax effect of Non-GAAP adjustments			1,439				(83	)			22				1,356				976
Non-GAAP net income (loss)		$	8,347			$	2,795			$	(11,534	)		$	11,142			$	(21,549	)
Non-GAAP net income (loss) as a % of revenue			8.8	%			3.1	%			(17.7	)%			6.0	%			(17.1	)%
ADJUSTED EBITDA:
GAAP net income (loss)		$	9,305			$	(3,303	)		$	(17,433	)		$	6,002			$	(28,124	)
Stock-based compensation expense			2,609				2,615				2,340				5,224				5,617
Amortization of purchased intangible assets			7				8				153				15				338
Depreciation of acquisition-related fixed asset step-up			15				17				24				32				43
Acquisition and asset sale related costs (recoveries)			638				905				(36	)			1,543				127
Retention costs related to acquisition			1,359				1,451				—				2,810				—
End-of-life related inventory write-down			—				—				3,257				—				2,680
Accelerated depreciation			—				—				157				—				331
Restructuring charges (recoveries)			—				(18	)			135				(18	)			135
Asset impairment charges			30				413				—				443				—
Facility shutdown related costs			209				300				—				509				—
Litigation settlement			(12	)			49				—				37				—
Gain on asset sale			(1,866	)			(114	)			—				(1,980	)			—
Unrealized foreign exchange (gain) loss, net (3)			(5,386	)			555				(153	)			(4,831	)			(3,672	)
Interest expense, net			363				284				80				647				202
Income tax provision			2,521				572				191				3,093				823
Depreciation expense			3,438				4,035				5,771				7,473				11,774
Adjusted EBITDA		$	13,230			$	7,769			$	(5,514	)		$	20,999			$	(9,726	)
Adjusted EBITDA as a % of revenue			13.9	%			8.7	%			(8.5	)%			11.4	%			(7.7	)%
BASIC AND DILUTED NET INCOME (LOSS) PER SHARE:
GAAP basic net income (loss) per share		$	0.17			$	(0.06	)		$	(0.34	)		$	0.11			$	(0.55	)
GAAP diluted net income (loss) per share		$	0.17			$	(0.06	)		$	(0.34	)		$	0.11			$	(0.55	)
Non-GAAP basic net income (loss) per share		$	0.16			$	0.05			$	(0.22	)		$	0.21			$	(0.42	)
Non-GAAP diluted net income (loss) per share		$	0.15			$	0.05			$	(0.22	)		$	0.19			$	(0.42	)
SHARES USED TO COMPUTE GAAP AND NON-GAAP BASIC NET INCOME (LOSS) PER SHARE			53,488				53,146				51,634				53,518				51,178
SHARES USED TO COMPUTE GAAP DILUTED NET INCOME (LOSS) PER SHARE			56,095				53,146				51,634				55,999				51,178
SHARES USED TO COMPUTE NON-GAAP DILUTED NET INCOME (LOSS) PER SHARE			57,307				57,344				51,634				57,327				51,178
(3) The non-GAAP financial measures for the three and six months ended June 30, 2021, and the three months ended March 31, 2022, have been adjusted to conform to the current period presentation by removing unrealized foreign exchange (gain) loss, net.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20220725005253/en/

NeoPhotonics Corporation

Beth Eby, Chief Financial Officer

+1-408-895-6086

ir@neophotonics.com



Sapphire Investor Relations, LLC

Erica Mannion, Investor Relations

+1-617-542-6180

ir@neophotonics.com

Source: NeoPhotonics Corporation

FAQ

What was NeoPhotonics' revenue for Q2 2022?

NeoPhotonics reported a revenue of $95 million for Q2 2022.

How much did NeoPhotonics' revenue grow year-over-year in Q2 2022?

The revenue grew by 46% year-over-year.

What percentage of NeoPhotonics' revenue came from 400G products in Q2 2022?

Products for 400G and above applications comprised 64% of total revenue.

Did NeoPhotonics make a profit in Q2 2022?

Yes, NeoPhotonics reported a GAAP operating profit of $6.4 million.

What were the main challenges NeoPhotonics faced in Q2 2022?

Supply chain constraints negatively impacted revenue by approximately $10 million.